Condition
Childhood Brain Tumors
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07457255Not ApplicableCompletedPrimary
Late Endocrine and Metabolic Consequences After Childhood Brain Tumor Treatment
NCT06770335Not ApplicableNot Yet Recruiting
The FLaME Cognitive Rehabilitation Study for Childhood Brain Tumour
NCT00003458Phase 2CompletedPrimary
Antineoplaston Therapy in Treating Children With Brain Tumors
Showing all 3 trials